Lion Point Capital’s GH Research GHRS Stock Holding History

Lion Point Capital’s Portfolio GHRS Stock Details GHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$143K	Hold	10,200	–	–	0.86%	32
2025 Q4	$130K	Buy	+10,200	New	+$139K	0.67%	37

Other funds holding GHRS

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

TCA

Troluce Capital Advisors Dorado, Puerto Rico $1.63B AUM 37.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Lion Point Capital's GHRS Position: Q1 2026 in Review

Lion Point Capital held its GH Research (GHRS) position steady in Q1 2026 at 10,200 shares worth $143K. The position accounts for 0.86% of the portfolio, ranked #32.

Lion Point Capital first reported a position in GHRS in Q4 2025 and has held it in 2 quarters since. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

Lion Point Capital held 10,200 shares of GH Research worth $143K as of Q1 2026.
Lion Point Capital left its GH Research share count unchanged in Q1 2026.
GH Research made up 0.86% of Lion Point Capital's portfolio in Q1 2026, its #32 holding.
Lion Point Capital first reported a position in GH Research in Q4 2025 and has held it in 2 quarters since.
54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on Lion Point Capital's 13F filing for Q1 2026, filed 15 May 2026.